載入...
Current issues and perspectives in PD-1 blockade cancer immunotherapy
Programmed cell death 1 (PD-1) signal receptor blockade has revolutionized the field of cancer therapy. Despite their considerable potential for treating certain cancers, drugs targeting PD-1 still present two main drawbacks: the substantial number of unresponsive patients and/or patients showing re...
Na minha lista:
| 發表在: | Int J Clin Oncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Singapore
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7192862/ https://ncbi.nlm.nih.gov/pubmed/31900651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-019-01588-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|